---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-21-019698"
form_type: "8-K"
ticker: "SFES"
cik: "0000086115"
company_name: "SAFEGUARD SCIENTIFICS INC"
filed_at: "2021-08-12T23:59:59+00:00"
generated_at: "2026-06-29T14:19:05.693719+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Safeguard Scientifics Q2 net loss narrows to $0.3M; expects $43M from Flashtalking sale

## Summary
- Net loss of $0.3M ($0.02 per share) vs loss of $9.9M ($0.48) in Q2 2020; improvement driven by $9.2M in gains.
- Receives $3.4M cash from Velano Vascular sale, recording a $1.8M gain; no new deployments in Q2.
- Bright Health IPO converted preferred equity to 1,322,484 shares valued at $22.7M (June 30); value fell to ~$11M by Aug 10.
- Flashtalking signs definitive agreement to be acquired by Mediaocean; Safeguard expects ~$43M cash in Q3 2021.
- Carrying value of ownership interests $60.1M (cost $173.5M); recorded $2.5M impairment on other interests.

## SEC filing metadata
- accession: 0001437749-21-019698
- form_type: 8-K
- ticker: SFES
- cik: 0000086115
- company_name: SAFEGUARD SCIENTIFICS INC
- filed_at: 2021-08-12T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/86115/000143774921019698/0001437749-21-019698-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/86115/000143774921019698/sfe20210811_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-21-019698
- JSON: https://secwatch.observer/filing/0001437749-21-019698.json
- Plain text: https://secwatch.observer/filing/0001437749-21-019698.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.